IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cynapsus Therapeutics Inc

CUSIP: 23257Y156 | 1 institutional holders

Quarters

Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2016

Dafna Capital Management LLC33,995
0.0% of portfolio›$564
StyleTurnoverLocationFiled
Dafna Capital Management LLC
33,995$5640.0%ValueMediumLos Angeles, CA2016-08-15